EP 0980257 A1 20000223 - USE OF VIRUS-LIKE PARTICLES AS ADJUVANTS
Title (en)
USE OF VIRUS-LIKE PARTICLES AS ADJUVANTS
Title (de)
VERWENDUNG VON VIRUSÄHNLICHEN PARTIKELN ALS ADJUVANTIEN
Title (fr)
UTILISATION DE PARTICULES DE TYPE VIRAL EN TANT QU'ADJUVANTS
Publication
Application
Priority
- US 9808146 W 19980422
- US 4526297 P 19970501
Abstract (en)
[origin: WO9850071A1] Adjuvant formulations are provided that contain nonreplicating virus-like particles (VLPs). The VLPs can be derived from any of several viruses and are useful for enhancing the immunological response to a selected antigen, wherein the antigen is distinct from the particles.
IPC 1-7
IPC 8 full level
A61K 39/102 (2006.01); A61K 39/116 (2006.01); A61K 39/12 (2006.01); A61K 39/29 (2006.01); A61K 39/39 (2006.01)
CPC (source: EP)
A61K 39/095 (2013.01); A61K 39/102 (2013.01); A61K 39/12 (2013.01); A61K 39/292 (2013.01); A61K 39/39 (2013.01); A61K 2039/5258 (2013.01); A61K 2039/55505 (2013.01); A61K 2039/55555 (2013.01); A61K 2039/55566 (2013.01); A61K 2039/55594 (2013.01); A61K 2039/6037 (2013.01); A61K 2039/70 (2013.01); C12N 2710/20023 (2013.01); C12N 2710/20034 (2013.01); C12N 2730/10123 (2013.01); C12N 2730/10134 (2013.01)
Citation (search report)
See references of WO 9850071A1
Designated contracting state (EPC)
AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE
DOCDB simple family (publication)
WO 9850071 A1 19981112; AU 7254598 A 19981127; AU 750702 B2 20020725; CA 2288129 A1 19981112; EP 0980257 A1 20000223; JP 2002508748 A 20020319
DOCDB simple family (application)
US 9808146 W 19980422; AU 7254598 A 19980422; CA 2288129 A 19980422; EP 98919845 A 19980422; JP 54812898 A 19980422